Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Carla F. Kim

EZH2 Inhibition Sensitizes BRG1 and EGFR Mutant Lung Tumours to TopoII Inhibitors

Nature

Multidisciplinary

2015

English

Using Stem Cell Biology to Design Precision Medicine for Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Related publications

Inhibition of Hsp90 Down-Regulates Mutant Epidermal Growth Factor Receptor (EGFR) Expression and Sensitizes EGFR Mutant Tumors to Paclitaxel

Cancer Research

Oncology

2008

English

Glycolysis Inhibition Sensitizes Non-Small Cell Lung Cancer With T790M Mutation to Irreversible EGFR Inhibitors via Translational Suppression of McL-1 by AMPK Activation

Molecular Cancer Therapeutics

Cancer Research

Oncology

2013

English

EZH2 Inhibition Re-Sensitizes Multidrug Resistant B-Cell Lymphomas to Etoposide Mediated Apoptosis

English

A Case of EGFR Mutant Lung Adenocarcinoma That Acquired Resistance to EGFR-tyrosine Kinase Inhibitors With MET Amplification and Epithelial-To-Mesenchymal Transition

OncoTargets and Therapy

Oncology

Pharmacology

2015

English

Hsp90 Inhibition Overcomes HGF-Triggering Resistance to EGFR-TKIs in EGFR-Mutant Lung Cancer by Decreasing Client Protein Expression and Angiogenesis

Journal of Thoracic Oncology

English

Rhein Sensitizes Human Pancreatic Cancer Cells to EGFR Inhibitors by Inhibiting STAT3 Pathway

Journal of Experimental and Clinical Cancer Research

Cancer Research

Oncology

2019

English

Dual Inhibition of EGFR With Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer With and Without T790M Mutations

Cancer Discovery

Oncology

2014

English

WZ4002, a Third-Generation EGFR Inhibitor, Can Overcome Anoikis Resistance in EGFR-mutant Lung Adenocarcinomas More Efficiently Than SRC Inhibitors

Laboratory Investigation

English

816 Autophagy Inhibition Sensitizes Targeted Therapy-Resistant Melanoma to MEK1/2 Inhibitors

Journal of Investigative Dermatology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Carla F. Kim

EZH2 Inhibition Sensitizes BRG1 and EGFR Mutant Lung Tumours to TopoII Inhibitors

Using Stem Cell Biology to Design Precision Medicine for Non-Small Cell Lung Cancer

Related publications

Inhibition of Hsp90 Down-Regulates Mutant Epidermal Growth Factor Receptor (EGFR) Expression and Sensitizes EGFR Mutant Tumors to Paclitaxel

Glycolysis Inhibition Sensitizes Non-Small Cell Lung Cancer With T790M Mutation to Irreversible EGFR Inhibitors via Translational Suppression of McL-1 by AMPK Activation

EZH2 Inhibition Re-Sensitizes Multidrug Resistant B-Cell Lymphomas to Etoposide Mediated Apoptosis

A Case of EGFR Mutant Lung Adenocarcinoma That Acquired Resistance to EGFR-tyrosine Kinase Inhibitors With MET Amplification and Epithelial-To-Mesenchymal Transition

Hsp90 Inhibition Overcomes HGF-Triggering Resistance to EGFR-TKIs in EGFR-Mutant Lung Cancer by Decreasing Client Protein Expression and Angiogenesis

Rhein Sensitizes Human Pancreatic Cancer Cells to EGFR Inhibitors by Inhibiting STAT3 Pathway

Dual Inhibition of EGFR With Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer With and Without T790M Mutations

WZ4002, a Third-Generation EGFR Inhibitor, Can Overcome Anoikis Resistance in EGFR-mutant Lung Adenocarcinomas More Efficiently Than SRC Inhibitors

816 Autophagy Inhibition Sensitizes Targeted Therapy-Resistant Melanoma to MEK1/2 Inhibitors